Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...

Comirnaty targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 subvariant ...

BioNTech's updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against ...

The Department of Health and Human Services will soon restart its program of offering free rapid tests for the virus through ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and olderData demonstrate that the Omicron KP.2-adapted COVID ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

The company's best days as a top pandemic vaccine supplier might be over, but it still has enough potential to be compelling.

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it's estimated COVID shots have ...